PHAROAH, P.D, PALMIERI, R.T, RAMUS, S.J., GAYTHER, S.A, ANDRULIS IL, ANTON-CULVER H, ANTONENKOVA N, ANTONIOU AC, GOLDGAR D; BCFR INVESTIGATORS, BEATTIE MS, BECKMANN MW, BIRRER MJ, BOGDANOVA N, BOLTON KL, BREWSTER W, BROOKS-WILSON A, BROWN R, BUTZOW R, CALDES T, CALIGO MA, CAMPBELL I, CHANG-CLAUDE J, CHEN YA, COOK LS, COUCH FJ, CRAMER DW, CUNNINGHAM JM, DESPIERRE E, DOHERTY JA, DÖRK T, DÜRST M, ECCLES DM, EKICI AB, EASTON D; EMBRACE INVESTIGATORS, FASCHING PA, DE FAZIO A, FENSTERMACHER DA, FLANAGAN JM, FRIDLEY BL, FRIEDMAN E, GAO B, SINILNIKOVA O; GEMO STUDY COLLABORATORS, GENTRY-MAHARAJ A, GODWIN AK, GOODE EL, GOODMAN MT, GROSS J, HANSEN TV, HARNETT P, ROOKUS M; HEBON INVESTIGATORS, HEIKKINEN T, HEIN R, HØGDALL C, HØGDALL E, IVERSEN ES, JAKUBOWSKA A, JOHNATTY SE, KARLAN BY, KAUFF ND, KAYE SB, CHENEVIX-TRENCH G; KCONFAB INVESTIGATORS AND THE CONSORTIUM OF INVESTIGATORS OF MODIFIERS OF BRCA1/2, KELEMEN LE, KIEMENEY LA, KJAER SK, LAMBRECHTS D, LAPOLLA JP, LÁZARO C, LE ND, LEMINEN A, LEUNEN K, LEVINE DA, LU Y, LUNDVALL L, MACGREGOR S, MAREES T, MASSUGER LF, MCLAUGHLIN JR, MENON U, MONTAGNA M, MOYSICH KB, NAROD SA, NATHANSON KL, NEDERGAARD L, NESS RB, NEVANLINNA H, NICKELS S, OSORIO A, PAUL J, PEARCE CL, PHELAN CM, PIKE MC, RADICE P, ROSSING MA, SCHILDKRAUT JM, SELLERS TA, SINGER CF, SONG H, STRAM DO, SUTPHEN R, LINDBLOM A; SWE-BRCA INVESTIGATORS, TERRY KL, TSAI YY, VAN ALTENA AM, VERGOTE I, VIERKANT RA, VITONIS AF, WALSH C, WANG-GOHRKE S, WAPPENSCHMIDT B, WU, A.H, ZIOGAS, A, BERCHUCK, A, RISCH, H.A and the OVARIAN CANCER ASSOCIATION CONSORTIUM.
(2011)
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.
Clinical Cancer Research, 17(11), 3742-3750.